Maravai LifeSciences Holdings, Inc.
MRVI
$2.45
$0.062.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -194.72M | -164.92M | -147.05M | -226.86M | -134.29M |
| Total Depreciation and Amortization | 58.86M | 58.02M | 56.87M | 55.32M | 54.38M |
| Total Amortization of Deferred Charges | 2.26M | 2.62M | 2.90M | 2.98M | 2.97M |
| Total Other Non-Cash Items | 110.02M | 103.38M | 103.44M | 194.75M | 101.39M |
| Change in Net Operating Assets | 2.42M | 7.45M | -8.69M | 3.71M | 6.48M |
| Cash from Operations | -21.16M | 6.54M | 7.47M | 29.89M | 30.92M |
| Capital Expenditure | -22.55M | -29.23M | -29.66M | -40.61M | -47.84M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -18.99M | -18.63M | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.28M | 4.66M | 5.34M | 8.32M | 9.00M |
| Cash from Investing | -40.26M | -43.20M | -24.32M | -32.29M | -38.85M |
| Total Debt Issued | 953.00K | 953.00K | 953.00K | -- | -- |
| Total Debt Repaid | -235.10M | -235.06M | -235.03M | -6.04M | -6.00M |
| Issuance of Common Stock | 13.00K | -- | -- | -- | 312.00K |
| Repurchase of Common Stock | -5.35M | -5.38M | -2.08M | -1.83M | -1.81M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.32M | -560.00K | 443.00K | 8.81M | 8.42M |
| Cash from Financing | -241.81M | -240.05M | -235.71M | 947.00K | 921.00K |
| Foreign Exchange rate Adjustments | -38.00K | 73.00K | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -303.26M | -276.64M | -252.56M | -1.45M | -7.01M |